KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Change in Taxes (2019 - 2025)

AbbVie (ABBV) has disclosed Change in Taxes for 7 consecutive years, with $646.0 million as the latest value for Q4 2025.

  • Quarterly Change in Taxes rose 135.83% to $646.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$762.0 million through Dec 2025, up 76.25% year-over-year, with the annual reading at -$762.0 million for FY2025, 76.25% up from the prior year.
  • Change in Taxes for Q4 2025 was $646.0 million at AbbVie, up from -$411.0 million in the prior quarter.
  • The five-year high for Change in Taxes was $646.0 million in Q4 2025, with the low at -$1.8 billion in Q2 2024.
  • Average Change in Taxes over 5 years is -$260.3 million, with a median of $42.0 million recorded in 2023.
  • The sharpest move saw Change in Taxes crashed 5892.31% in 2021, then skyrocketed 545.45% in 2022.
  • Over 5 years, Change in Taxes stood at -$662.0 million in 2021, then surged by 154.08% to $358.0 million in 2022, then grew by 14.8% to $411.0 million in 2023, then plummeted by 538.69% to -$1.8 billion in 2024, then surged by 135.83% to $646.0 million in 2025.
  • According to Business Quant data, Change in Taxes over the past three periods came in at $646.0 million, -$411.0 million, and -$1.4 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.